Rare diseases
Investigational molecules
Locations
Back to Greece973 clinical trials in Athens, Greece across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
GreeceA Study to Assess Safety and Efficacy of Surzetoclax Alone or with Etentamig in Adults with Relapsed or Refractory Multiple Myeloma
GreeceA Phase 2a Study of Empasiprubart IV Monotherapy in Adults with AChR‑Ab Seropositive Generalized Myasthenia Gravis
GreeceCevostamab, Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 1‑3 Lines of Therapy
GreecePhase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments
GreeceA Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease
GreeceStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
GreeceStudy of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer
GreeceWeekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature
GreeceA Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis
GreeceEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
GreeceA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
GreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on head and neck cancer, bladder cancer, and advanced solid tumors. Research includes innovative combination therapies and novel treatment approaches for various tumor types.
Studies evaluate new therapeutic combinations and their impact on patient survival rates.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome, lupus, and inflammatory conditions.
Focus on developing targeted therapies for chronic autoimmune conditions.
Research examining treatments for heart failure, cardiovascular disease prevention, and metabolic disorders including obesity.
Trials evaluating new therapeutic approaches for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
